Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in